Trial Profile
Distinct glucose-lowering properties in good responders treated with sitagliptin and alogliptin.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Dec 2015 New trial record